Currently Viewing:
Patient-Centered Oncology Care
Ian Manners Outlines Pharma's Participation in Providing Financial Assistance for Patients
May 23, 2018
Dr Mark Fleury on 21st Century Cures and Cancer Care
May 21, 2018
Ian Manners Explains How Vivor Empowers Providers and Financial Navigators
May 03, 2018
Dr Thomas Graf: Personalizing Cancer Care Payment Models
April 16, 2018
Dr Stacey McCullough Discusses Teamwork and Collaboration in Oncology
April 13, 2018
Torrie Fields: Collecting and Using Data Can Better Inform a Patient
April 12, 2018
Dr Thomas Graf Discusses the Effect of Novel Therapies on Private Coverage
April 06, 2018
Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians
April 05, 2018
Dr Stacey McCullough on the Pharmacist's Role in Patient Education
March 29, 2018
Dr Thomas Graf: How the Impact of Novel Therapies Varies Among Stakeholders
March 22, 2018
Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence
March 18, 2018
Ian Manners Explains the Impact of Patient Financial Assistance Programs
March 17, 2018
Dr Thomas Graf on the Impact of New Therapies in Oncology
March 12, 2018
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
March 02, 2018
Dr Brenton Fargnoli on Fixing Issues Physicians Have With EHRs
February 18, 2018
Kathleen Lokay: Implementing Value in Clinical Pathways
February 13, 2018
Currently Reading
Jason Harris Discusses the Importance of Real-World Evidence
February 11, 2018
Kathleen Lokay on Educating Patients on Treatment Options
January 28, 2018
Dr Brenton Fargnoli Discusses the Creation of a Learning Health System
January 25, 2018

Jason Harris Discusses the Importance of Real-World Evidence

Jason Harris, associate director of policy and programs at National Health Council, notes the importance of using real-world evidence to support value in payment models.
 


Jason Harris, associate director of policy and programs at National Health Council, notes the importance of using real-world evidence to support value in payment models.

Transcript

Why is it important to incorporate real-world evidence and value into payment models?

I think 1 thing specifically on value is that we want to be getting our patients the best care possible. So, we want to make sure we are tying those outcomes back to what is important to that patient value and real-world evidence is 1 way we can do that a little bit quicker if we are able to unlock some of the data concerns behind it.

What are the barriers that remain to regularly using and incorporating real-world evidence?

I think 1 thing right now is that the data that is out there is not correlated in a way that folks can use it “fit-for-purpose” or “fit-for-use,” whether it be a payer or the FDA with drug development and the same thing goes for value. How do you incorporate something that’s important to a patient into a bigger more holistic picture that then can spit out a number or tie you to payment back to it?

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!